Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum.
暂无分享,去创建一个
Xiangyi Liu | Xinxin Lu | Xiaohua Wan | Sheng Lu | Lijun Zhang | Shaohua Yu | Xinxin Lu | Xiangyi Liu | Shaohua Yu | Xiaohua Wan | S. Lu | Lijun Zhang
[1] G. Bulla,et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease , 2002, Hepatology.
[2] Xiaohua Li,et al. Serum Golgi Phosphoprotein 2 level: A better marker than alpha‐fetoprotein for diagnosing early hepatocellular carcinoma , 2009, Hepatology.
[3] Jin-Ming Lin,et al. Evaluation of alpha-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases. , 2009, Analytica chimica acta.
[4] Ji Hoon Lee,et al. Advent of innovative chemiluminescent enzyme immunoassay. , 2010, Biosensors & bioelectronics.
[5] Zhao Yue,et al. Magnetic-particle-based, ultrasensitive chemiluminescence enzyme immunoassay for free prostate-specific antigen. , 2013, Analytica chimica acta.
[6] Yu Zhao,et al. Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases , 2009, Annals of clinical biochemistry.
[7] B. Cao,et al. Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA , 2012, Journal of biomedical research.
[8] D. Chan,et al. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma , 2011, Clinical chemistry and laboratory medicine.
[9] Baruch S Blumberg,et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] Mary Ann Comunale,et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. , 2005, Journal of hepatology.
[11] Yunshan Wang,et al. An improved portable biosensing system based on enzymatic chemiluminescence and magnetic immunoassay for biological compound detection , 2014 .
[12] Xiaomei Pei,et al. Sandwich-type immunosensors and immunoassays exploiting nanostructure labels: A review. , 2013, Analytica chimica acta.
[13] Jin-Ming Lin,et al. Magnetic particle-based chemiluminescence enzyme immunoassay for free thyroxine in human serum. , 2009, Journal of pharmaceutical and biomedical analysis.
[14] Jing Zhang,et al. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections. , 2014, Diagnostic microbiology and infectious disease.
[15] Xinxin Lu,et al. Golgi protein 73(GP73), a useful serum marker in liver diseases , 2011, Clinical chemistry and laboratory medicine.
[16] Jin‐Ming Lin,et al. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[17] Xiaolin Fu,et al. Chemiluminescence enzyme immunoassay using magnetic nanoparticles for detection of neuron specific enolase in human serum. , 2012, Analytica chimica acta.
[18] Y. Qiao,et al. Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections , 2013, PloS one.
[19] Jin-Ming Lin,et al. Development of a highly sensitive magnetic particle-based chemiluminescence enzyme immunoassay for thyroid stimulating hormone and comparison with two other immunoassays. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[20] Jie Rao,et al. Development of a rapid and high-performance chemiluminescence immunoassay based on magnetic particles for protein S100B in human serum. , 2013, Luminescence : the journal of biological and chemical luminescence.
[21] S. Du,et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma , 2010, Gut.
[22] R. Kladney,et al. GP73, a novel Golgi-localized protein upregulated by viral infection , 2000, Gene.
[23] Xin Yin,et al. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis , 2012, BMC Cancer.
[24] Hua He,et al. Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[25] L. Frati,et al. Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers , 2013, Tumor Biology.
[26] Haifeng Xu,et al. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival , 2011, Journal of gastroenterology and hepatology.
[27] N. Probst-Hensch,et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas , 2009, Hepatology.
[28] R. Ni,et al. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma , 2013, Oncology letters.
[29] Jin‐Ming Lin,et al. Evaluation of carbohydrate antigen 50 in human serum using magnetic particle-based chemiluminescence enzyme immunoassay. , 2007, Analytica chimica acta.
[30] Suwen Qi,et al. A rapid and sensitive chemiluminescence immunoassay based on magnetic particles for squamous cell carcinoma antigen in human serum. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[31] Yonggoo Kim,et al. Evaluation of enzymatic BM Test HbA1c on the JCA-BM6010/C and comparison with Bio-Rad Variant II Turbo, Tosoh HLC 723 G8, and AutoLab immunoturbidimetry assay , 2013, Clinical chemistry and laboratory medicine.
[32] Qiaoliang Li,et al. Determining the concentration of procalcitonin using a magnetic particles-based chemiluminescence assay for the clinical diagnosis of sepsis. , 2013, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[33] Shuo Liang,et al. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population , 2010, Medical oncology.